Free Otolaryngology CME
1 - 1 of 1 results
-
CMEFREE
Med-IQ CME: Updates in R/M HNSCC From ESMO25: Novel Targeted Agents and Immunotherapies
In this MedX activity, Robert Haddad, MD, explores the latest clinical data for emerging novel therapies for recurrent/metastatic head and neck squamous cell carcinoma with an emphasis on results presented at ESMO 2025.
See full details chevron_right- Cost: Free
- Credit hours: 0.5 AMA PRA Category 1 Credit™
- CME credits awarded by: Med-IQ
- Format: On-Demand Online
- Material last updated: 12/17/2025
- Expiration of CME credit: 12/16/2026
